Support Groups with Filters
New Statistical Report Reveals Primary Brain and Central Nervous System Tumors as Second Most Common Cancer Type in Adolescents and Young Adults
CHICAGO (May 7, 2024)—Today, the American Brain Tumor Association (ABTA), in partnership with the National Institutes of Health’s National Cancer Institute (NCI) Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) program and the Central Brain Tumor Registry of the United States (CBTRUS), unveiled a new report shedding light on the prevalence of primary brain and other central nervous system (CNS) tumors among adolescents and young adults (AYAs) between the ages of 15 and 39.
ABTA President and CEO Ralph A. DeVitto Announces Retirement
Chicago, IL (May 6, 2024)—The American Brain Tumor Association (ABTA) announced that President and CEO Ralph A. DeVitto has informed the Board of Directors of his intention to retire from ABTA in January 2025, after leading the organization for nearly seven years.
A Dose Escalation and Expansion Study of Sonodynamic Therapy With SONALA-001 in Combination With Exablate 4000 Type-2 MR-guided Focused Ultrasound in Patients With Recurrent or Progressive Glioblastoma Multiforme
Featured Clinical Study A Dual Phase 1/2, Investigator Initiated Study to Determine the Maximum Tolerated Dose, Safety, and Efficacy of 186Rhenium Nanoliposomes (186RNL) in Recurrent Glioma (CTRC# 12-02) Study Sponsor:
Inaugural Year of Meet Hope Head On Yields $10M Investment in Our Mission
Discover how we’re closer to tripling our investment in research thanks to your support of Meet Hope Head On!
Incorporating Diet & Nutrition in Your Brain Tumor Care
Get tips for optimizing what you eat during brain tumor treatment and in recovery.
When Melanoma Metastasizes to the Brain
Explore the risks of melanoma metastasizing to the brain and join an upcoming webinar to empower yourself or a loved one.
